What is the recommended doripenem dosing for an adult with a lower respiratory tract infection, and how should it be adjusted for different levels of renal function?

Doripenem Dosing for Lower Respiratory Tract Infections

Standard Dosing for Normal Renal Function

For adults with lower respiratory tract infections and creatinine clearance >50 mL/min, administer doripenem 500 mg intravenously every 8 hours, infused over 1 hour. 1, 2

• This regimen achieves adequate pharmacodynamic targets (≥35% time above MIC) for pathogens with doripenem MICs ≤1 mg/L in >90% of patients. 1
• For pathogens with higher MICs (2-4 mg/L), extend the infusion time to 4 hours to improve target attainment and maximize bacterial killing. 1, 3

Dosing Adjustments for Renal Impairment

Moderate Renal Impairment (CrCl 30-50 mL/min)

• Reduce dose to 250 mg intravenously every 8 hours, infused over 1 hour. 1
• This reduced regimen maintains efficacy against pathogens with MICs ≤2 mg/L. 1

Severe Renal Impairment (CrCl 10-29 mL/min)

• Administer 250 mg intravenously every 12 hours, infused over 1 or 4 hours. 1
• The extended dosing interval compensates for markedly reduced drug clearance. 1

Patients on Intermittent Hemodialysis

• Give 1 gram intravenously immediately after each hemodialysis session (typically three times weekly). 4
• This posthemodialysis dosing maintains adequate trough concentrations (≥2.4 mg/L) between dialysis sessions in anuric patients. 4
• Critical caveat: This regimen may be insufficient in oliguric patients with residual renal function; monitor clinical response closely. 4

Patients on Continuous Renal Replacement Therapy (CRRT)

• Standard dosing recommendations apply, but significant interpatient variability exists. 2
• Consider therapeutic drug monitoring when available, as CRRT clearance averages 123 mL/min but varies widely (range 81-165 mL/min). 4

Augmented Renal Clearance (CrCl ≥90 mL/min)

In critically ill patients with augmented renal clearance, standard 500 mg every 8 hours dosing is frequently suboptimal. 3, 5

• Increase to 1 gram every 8 hours as a 4-hour infusion to achieve adequate exposure for pathogens with MICs >1 mg/L. 3, 5
• Alternatively, consider continuous infusion after a loading dose to maintain consistent drug levels above the MIC. 6
• Augmented clearance is common in younger, critically ill patients and can reduce doripenem concentrations by 40-60% compared to normal renal function. 5

Infusion Duration Considerations

• Standard 1-hour infusions are adequate for highly susceptible organisms (MIC ≤1 mg/L). 1, 2
• Extend to 4-hour infusions when:
  • The pathogen MIC is 2-4 mg/L 1, 3
  • The patient has augmented renal clearance 3, 5
  • Treating Pseudomonas aeruginosa or other less susceptible gram-negative organisms 1
• Prolonged infusions increase the percentage of the dosing interval that drug concentrations remain above the MIC, which is the critical pharmacodynamic parameter for carbapenem efficacy. 1, 2

Population-Specific Pharmacokinetic Differences

• Korean and Asian populations demonstrate approximately 30% lower doripenem clearance compared to Caucasian populations, independent of renal function. 3
• No routine dose adjustment is required based on ethnicity alone, but be aware that standard dosing may achieve higher drug exposures in Asian patients. 3
• ICU versus non-ICU location does not significantly affect doripenem pharmacokinetics when renal function is equivalent. 2

Critical Pitfalls to Avoid

• Never use standard dosing in patients with CrCl >90 mL/min without extending infusion time or increasing dose, as this results in subtherapeutic concentrations for 40-60% of the dosing interval. 5
• Do not assume renal dosing charts apply to CRRT patients—hemofilter clearance varies dramatically (42-165 mL/min) and may require individualized dosing. 4
• Avoid underdosing in severe pneumonia caused by Pseudomonas aeruginosa, which often has MICs of 2-4 mg/L requiring prolonged infusions or higher doses. 1, 3